RPG Life Sciences Limited — Others, 25-01-2025: Copy of Newspaper Publication

RPG Life Sciences has announced a board meeting to discuss the financial results for the quarter and half-year ended December 31, 2024. The publication of these unaudited results reflects the company’s ongoing transparency in reporting. This update may bolster investor confidence by providing insights into the company's performance, potentially highlighting growth opportunities. The focus on timely financial disclosures aligns with a strategic intent to maintain open communication with shareholders, fostering a positive outlook for future operations and management decisions. Investors should watch for how these results impact overall market sentiment.